ETHANOL ABLATION FOR TREATING CYSTIC THYROID NODULES

Overview

About this study

We want to determine the efficacy and safety, and the rate and type of side effects of this technique; as well as to delineate the clinical pathologic outcomes of the patients with thyroid cysts treated with Percutaneous ethanol injection (PEI) at Mayo Clinic, Rochester MN, since there is limited information of the use of this technique in the American literature.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Target accrual:  

We will study Mayo Clinic Rochester patients with thyroid cysts (either completely cystic or predominantly cystic thyroid nodules) that were treated with PEI at Mayo Clinic from January 1, 2000 to August 31, 2016.

Subject population: 

All patients >18 years of age with thyroid cysts (either completely cystic or predominantly cystic thyroid nodules) that were treated with PEI at Mayo Clinic without enough information in the EMR for follow up

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

M. Regina Castro, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20303250

Mayo Clinic Footer